
Repurposing a failed class of schizophrenia drugs to treat menopausal symptoms
- Article
- Apr 2, 2023
- #Mentalhealth
The science and serendipity behind neurokinin-3 receptor antagonists
The science and serendipity behind neurokinin-3 receptor antagonists